On the other hand, the use of VEGF-blocking therapies (e.g., bevacizumab: anti-VEGF monoclonal antibody in the treatment of cancer) is associated with side effects such as hypertension and proteinuria [66,67,68,69,70]. Here, VEGFA is linked to Hypertension.